Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness of Individualized Automatic Target Coaching Message Based on the Metrics of Continuous Glucose Monitoring and Depressive Symptom in Patients With Insulin-treated Type 2 Diabetes: A Randomized Controlled Trial

NCT06769906 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT06769906
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06769906 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness of Individualized Automatic Target Coaching Message Based on the Metrics of Continuous Glucose Monitoring and Depressive Symptom in Patients With Insulin-treated Type 2 Diabetes: A Randomized Controlled Trial
Lead sponsor
Samsung Medical Center
Phase
Not applicable
Overall status
Completed
Start date
January 9, 2025
Completion date
July 2, 2025
Enrollment
46 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

continuous glucose measurement, depressive symptom, diabetes mellitus type 2